Anhui Redpont Biotechnology Co., Ltd. announced that it will receive CNY 50,000,000 in an equity round of funding on December 30, 2019. The transaction will include participation from returning investor Nanjing Red Sun Co.,Ltd. (SZSE:000525) to maintain its 100% stake in the company after the transaction. The registered capital of the company will increase from CNY 218,000,000 to CNY 268,000,000. The transaction was approved at the 18th meeting of the 8th session of the board of directors of the investor.